CELLTRION PHARM, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95,800 KRW | -2.94% |
|
-2.34% | +3.90% |
| Jan. 16 | Celltrion Holdings Actively Pursuing Nasdaq Listing | MT |
| Jan. 02 | Celltrion's Shares Climb After Merger With Affiliate | DJ |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2019 | 174B 128M | Sales 2020 | 234B 173M | Capitalization | 8,705B 6.44B |
|---|---|---|---|---|---|
| Net income 2019 | 8.6B 6.37M | Net income 2020 | 20.94B 15.5M | EV / Sales 2019 | 9.06 x |
| Net Debt 2019 | 149B 110M | Net Debt 2020 | 163B 121M | EV / Sales 2020 | 38 x |
| P/E ratio 2019 |
166
x | P/E ratio 2020 |
417
x | Employees | 328 |
| Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 47.03% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.94% | ||
| 1 week | -0.83% | ||
| Current month | -0.31% | ||
| 1 month | +6.44% | ||
| 3 months | -6.99% | ||
| 6 months | +24.03% | ||
| Current year | +3.90% |
1 week
95 700.00
99 500.00
1 month
88 000.00100 900.00
Current year
87 700.00133 300.00
1 year
57 714.29133 300.00
3 years
53 523.81158 245.82
5 years
23 556.96236 729.00
10 years
5 962.91236 729.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jeong-Soo Suh
CEO | Chief Executive Officer | 64 | 16-03-27 |
Yu-Jin Jeon
DFI | Director of Finance/CFO | 51 | - |
Jung-Jin Seo
CHM | Chairman | 66 | 09-01-22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 66 | 09-01-22 |
Jeong-Soo Suh
CEO | Chief Executive Officer | 64 | 16-03-27 |
Haeng-Ok Kim
BRD | Director/Board Member | 72 | 14-03-27 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.75% | 2 M€ | -14.14% | ||
| 0.03% | 15 M€ | +18.83% | ||
| 0.01% | 2,867 M€ | +11.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 95,800 | -2.94% | 179,669 |
| 24-05-16 | 98,700 | +2.07% | 84,143 |
| 24-05-14 | 96,700 | 0.00% | 53,203 |
| 24-05-13 | 96,700 | -1.43% | 76,829 |
| 24-05-10 | 98,100 | +1.55% | 110,780 |
End-of-day quote Korea S.E., May 16, 2024
More quotes
Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Companyâs products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +3.90% | 3.03B | |
| +21.59% | 44.15B | |
| +23.03% | 23.02B | |
| +18.22% | 15.33B | |
| +12.26% | 13.74B | |
| +52.55% | 12.16B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.66B |
- Stock Market
- Equities
- A068760 Stock
